Zinc supplementation and 60-day mortality in patients receiving total parenteral nutrition: a single-center experience

Key Points

• Higher zinc supplementation during total parenteral nutrition is linked to reduced 60-day mortality, indicating its potential benefit.
• Patients receiving at least 2 mg of zinc per day had notably improved survival rates compared to those who did not.
• Retrospective cohort analysis conducted at a single center assessed the impact of zinc on patient outcomes in TPN.
• Potential clinical implications highlight the need for prospective validation of zinc dosing in TPN regimens.

Abstract